Annual report pursuant to Section 13 and 15(d)

Schedule of Stock Option Activity (Details)

v3.22.1
Schedule of Stock Option Activity (Details) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]    
Shares outstanding beginning balance 848,819  
Weighted average grant price outstanding beginning balance $ 8.76  
Weighted average remaining contractual period outstanding beginning balance 8 years 7 months 2 days  
Aggregate intrinsic value outstanding beginning balance  
Shares granted 347,500  
Weighted average grant price granted $ 6.00  
Weighted average remaining contractual period granted 9 years 2 months 15 days  
Aggregate intrinsic value granted  
Shares exercised (13,042) 0
Weighted average grant price exercised $ 9.45  
Shares forfeited or expired (550,766)  
Weighted average grant price forfeited or expired $ 9.15  
Aggregate intrinsic value forfeited or expired  
Shares outstanding ending balance 632,511 848,819
Weighted average grant price outstanding ending balance $ 6.89 $ 8.76
Weighted average remaining contractual period outstanding ending balance 8 years 4 months 24 days  
Aggregate intrinsic value outstanding ending balance
Shares exercisable ending balance 206,732  
Weighted average grant price exercisable ending balance $ 9.14  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term 7 years 6 months 10 days  
Aggregate intrinsic value exercisable ending balance  
Shares vested and expected to vest 537,520  
Weighted average grant price vested and expected to vest $ 7.15  
Weighted average remaining contractual period vested and expected to vest 8 years 4 months 9 days  
Aggregate intrinsic value vested and expected to vest